发明名称 NOVEL COMPOUNDS AS HIF-1ALPHAINHIBITORS AND MANUFACTURING PROCESS THEREOF
摘要 The present invention relates to novel compounds as HIF-1α inhibitors, manufacturing process thereof, and a pharmaceutical compositions. The compounds according to the present invention having inhibition activity against HIF-1α, can be used as a therapeutic prevention and/or treatment for various solid cancers such as colon cancer, liver cancer, stomach cancer and breast cancer. Also, the compounds according to the present invention are useful in the treatment of diabetic retinopathy and rheumatoid arthritis, which are aggravated by HIF-1α-mediated VEGFA expression.
申请公布号 US2014228357(A1) 申请公布日期 2014.08.14
申请号 US201214347556 申请日期 2012.09.27
申请人 KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY ;DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION 发明人 Lee Kyeong;Won Mi-Sun;Kim Hwan-Mook;Park Song-Kyu;Lee Ki-Ho;Lee Chang-Woo;Kim Bo-Kyung;Ban Hyun-Seung;Chung Kyung-Sook;Ravi Naik
分类号 C07D487/04;C07C231/02;C07D295/182;C07C235/20;C07D295/108 主分类号 C07D487/04
代理机构 代理人
主权项 1. A compound represented by Formula I, pharmaceutically acceptable salt, hydrate or solvate thereof.wherein, R1 represents hydrogen, methyl, fluoro or chloro; R2 represents hydrogen or methyl; R3 represents, wherein, Ra represents dimethyl, cyclopropyl, N,N-dimethylaminoethyl or 2-furanylmethyl; Rb represents hydrogen, (S)-methyl or (R)-methyl; Re represents hydrogen, methyl, isopropyl, tert-butoxycarbonyl(Boc), 4-trifluoromethylbenzyl, hydroxyethyl or propynyl; and Rd represents Re represents hydrogen or hydroxyl; and n represents 1, 2 or 3.
地址 Daejeon KR